Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.

Keikhaei B, Mohseni AR, Norouzirad R, Alinejadi M, Ghanbari S, Shiravi F, Solgi G.

Eur Cytokine Netw. 2013 Mar;24(1):45-52. doi: 10.1684/ecn.2013.0328.

PMID:
23608554
2.

Cytokine profile of sickle cell disease in Oman.

Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D.

Am J Hematol. 2004 Dec;77(4):323-8.

3.

Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.

Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF.

J Leukoc Biol. 2009 Feb;85(2):235-42. doi: 10.1189/jlb.0708445. Epub 2008 Nov 12.

4.

Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.

Sarray S, Saleh LR, Lisa Saldanha F, Al-Habboubi HH, Mahdi N, Almawi WY.

Cytokine. 2015 Mar;72(1):43-7. doi: 10.1016/j.cyto.2014.11.030. Epub 2015 Jan 5.

PMID:
25569375
5.

Evaluation of reticulated platelets in patients with sickle cell diseases.

Noronha JF, Costa FF, Saad ST, Lorand-Metze IG, Grotto HZ.

Thromb Res. 2007;121(2):259-67. Epub 2007 May 22.

PMID:
17521711
6.

Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.

Tavakkoli F, Nahavandi M, Wyche MQ, Perlin E.

Hematology. 2004 Feb;9(1):61-4.

PMID:
14965870
7.

Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8.

Etienne-Julan M, Belloy MS, Decastel M, Dougaparsad S, Ravion S, Hardy-Dessources MD.

Haematologica. 2004 Jul;89(7):863-4.

8.
9.

Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Musa BO, Onyemelukwe GC, Hambolu JO, Mamman AI, Isa AH.

Clin Vaccine Immunol. 2010 Apr;17(4):602-8. doi: 10.1128/CVI.00145-09. Epub 2010 Feb 3.

10.

Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis.

Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA.

Blood. 1998 Oct 1;92(7):2551-5.

11.

Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in haemodialysis patients.

Taraz M, Khatami MR, Gharekhani A, Abdollahi A, Khalili H, Dashti-Khavidaki S.

Eur Cytokine Netw. 2012 Oct-Dec;23(4):179-86. doi: 10.1684/ecn.2013.0326.

PMID:
23360798
12.

Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70.

Adewoye AH, Klings ES, Farber HW, Palaima E, Bausero MA, McMahon L, Odhiambo A, Surinder S, Yoder M, Steinberg MH, Asea A.

Am J Hematol. 2005 Mar;78(3):240-2.

13.

Adhesion molecules and high-sensitivity C-reactive protein levels in patients with sickle cell beta-thalassaemia.

Kanavaki I, Makrythanasis P, Lazaropoulou C, Kattamis A, Tzanetea R, Kalotychou V, Rombos I, Papassotiriou I.

Eur J Clin Invest. 2012 Jan;42(1):27-33. doi: 10.1111/j.1365-2362.2011.02551.x. Epub 2011 May 25.

PMID:
21615396
14.

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.

Koren A, Segal-Kupershmit D, Zalman L, Levin C, Abu Hana M, Palmor H, Luder A, Attias D.

Pediatr Hematol Oncol. 1999 May-Jun;16(3):221-32.

PMID:
10326220
15.

Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.

Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.

Blood Cells Mol Dis. 2009 Jan-Feb;42(1):25-31. doi: 10.1016/j.bcmd.2008.08.003. Epub 2008 Oct 26.

PMID:
18954999
16.

Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.

Garrido VT, Proença-Ferreira R, Dominical VM, Traina F, Bezerra MA, de Mello MR, Colella MP, Araújo AS, Saad ST, Costa FF, Conran N.

Br J Haematol. 2012 Sep;158(6):788-97. doi: 10.1111/j.1365-2141.2012.09218.x. Epub 2012 Jul 6.

PMID:
22775554
17.

Hydroxyurea therapy in children severely affected with sickle cell disease.

Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ.

J Pediatr. 1996 Jun;128(6):820-8.

PMID:
8648542
18.

Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients.

Makis AC, Hatzimichael EC, Mavridis A, Bourantas KL.

Acta Haematol. 2000;104(4):164-8.

PMID:
11279305
19.

Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study.

El-Ghamrawy MK, Hanna WM, Abdel-Salam A, El-Sonbaty MM, Youness ER, Adel A.

J Pediatr (Rio J). 2014 May-Jun;90(3):286-92. doi: 10.1016/j.jped.2013.09.005. Epub 2014 Feb 5.

Items per page

Supplemental Content

Write to the Help Desk